Cover Image
市場調查報告書

合成生物學的全球市場

Synthetic Biology

出版商 Global Industry Analysts, Inc. 商品編碼 134341
出版日期 內容資訊 英文 240 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
合成生物學的全球市場 Synthetic Biology
出版日期: 2015年02月01日 內容資訊: 英文 240 Pages
簡介

本報告以合成生物學的全球市場為焦點,由直接取材及二次資訊調查中所獲得的市場資料和分析資訊,除了依應用領域(能源·化學,生物科技·醫藥品等)及地區(美國,加拿大,日本,歐洲,亞太地區,其他)別提供以2014-2020年這段期間為對象之交易金額實際成果與預測之外,更彙整過去6年的市場發展和51家主要·精銳參與企業的最新簡介等資料,為您概述為以下內容。

第1章 簡介,調查方法,產品定義

  • 調查的可靠性和報告的限制
  • 免責聲明
  • 資料的解釋和報告製作水準
    • 定量技術及分析法
  • 產品定義和調查的範圍

第2章 摘要整理

  • 展望
    • 概要基礎知識
    • 合成生物學:正在現實化的預言
    • 現狀及未來分析
    • 分析:各地區
    • 分析:各產品種類
    • 分析:各最終消費者市場
    • 主要的成長推動要素·主要的顧慮事項
    • 成長推動要素
    • 顧慮事項
    • 未來展望
  • 產業概要
    • 合成生物學- 需要推銷的新興領域
    • 合成生物學對生物科技的貢獻
    • Craig Venter的人工生命體:合成生物學領域的偉大事業
    • Gen9BioFab:合成生物學的劃時代成果
    • 合成生物學領域的主要發展:概要
    • 競爭情形
    • 合成生物學市場上的競爭
  • 市場趨勢,推動要素,及課題
    • 合成生物學是受惠還是滅亡之源
    • 進步彷彿停滯的合成生物學
    • 具有彈性的合成生物學研究
    • 美國和歐洲-加速的合成生物學領域的研究
    • 課題堆積如山的開發中國家中的合成生物學
    • 關係到合成生物學進步的系統生物學
    • DNA測序技術加速了合成生物學的成長
    • DNA定序成本的急劇下落促進市場的成長
    • 系統生物學促進合成生物學的進步
    • 食品外基礎需求的不足促進合成生物學市場的發展
    • 食品,水,能源統計
    • 合成生物學可否緩和食品安全性的疑慮
    • GM作物(基因改造農作物)的需求擴大拓展了成長的未來
    • 合成生物學為基礎的成分氣勢漸增、其他
  • 合成生物學的主要研究結果
    • 生物學者為了創造人工生命將人工染色體移植給酵母
    • 合成遺傳基因打開了藥物研發的新世界
    • 研究人員發表Peptoid Nanosheets的製造
    • 擊退病毒的合成生物學
    • 人工食品的合成生物學
    • 因應藻類相關問題的合成生物學
    • 具有水質檢驗可能性的合成生物學、其他
  • 合成生物學:概要
    • 簡介
    • 歷史背景
    • 合成生物學和遺傳基因重組技術 - 比較
    • 各領域的合成生物學的範圍
    • 工程
    • 化學
    • 主要實行技術
    • 定序
    • 製造
    • 試製
    • 測量
    • 市場:各產品
    • 核心產品/生物學的因素
    • 可能實現產品
    • 市場潛在性
    • 醫藥品
    • 工業
    • 農業
    • 生命科學研究
    • 再生能源
    • 潛在性用途
    • 低分子醫藥的生物內合成
    • 生命化學的擴大
    • 化學工業的持續性
    • 能源及環境
    • 生物材料及智慧材料生產
    • 合成生物學的社會經濟性興趣及風險
    • 生物武器的生產
    • 意外性放出
    • ROI
    • 跟其他領域的衝突
    • 漸進的演進
    • 理解不完全
    • 預期外的對生態系統產生的影響
    • 無法預測的遺傳基因變動
    • 日漸嚴重的問題
    • 產業團體
    • Synthetic Biology Industry Association(SynBIA)
    • Industry Association of Synthetic Biology(IASB)
  • 產品開發/銷售
  • 最近的產業趨勢
  • 主要企業
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 其他各國
  • 亞太地區
  • 其他地區

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6581

This report analyzes the worldwide markets for Synthetic Biology in US$ Thousands by the following Product Segments: Enabled Products, and Others. The report also analyzes the market by the following Application Areas: Energy and Chemicals, Biotechnology and Pharmaceuticals, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 51 companies including many key and niche players such as -

Amyris, Inc.
BP PLC
Chromatin Inc.
Evolva SA
Gevo, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • A Quick Primer
  • Synthetic Biology: Prediction Becoming Reality
  • Current and Future Analysis
  • Analysis by Region
  • Analysis by Product Segment
  • Analysis by End-Use Market
  • Key Growth Drivers and Major Concerns
  • Growth Drivers
  • Major Concerns
  • Future Outlook

2. INDUSTRY OVERVIEW

  • Synthetic Biology - An Emerging Discipline in Need of Promotion
  • Contribution of Synthetic Biology to Biotech
  • Craig Venter's Synthetic Life: Momentous Achievement in Synthetic Biology Field
    • Gibson Assembly®: Building Toolset for Synthetic Biology
  • Gen9's BioFab: Major Breakthrough in Synthetic Biology
  • Key Developments in the Synthetic Biology Field: A Synopsis
    • Synthetic Biology Products with Commercial Potential in the Future by End Market
  • Competitive Landscape
  • Competition in Synthetic Biology Market
    • Intrexon: Leader in Synthetic Biology Field
    • Key Factors Contributing to Intrexon's Success in Synthetic Biology Field
      • Proprietary Suite of Innovative Technologies
      • Unique ECC-based Business Model
      • A Synopsis of Intrexon's ECC Agreements: 2011-2013

3. MARKET TRENDS, DRIVERS, AND ISSUES

  • Is Synthetic Biology a Bane or Boon?
  • Synthetic Biology Exhibits Plateau in Awareness
  • Synthetic Biology Research Gathers Momentum
  • US and Europe - Propelling Research in the Field of Synthetic Biology
    • Table 1: Number of Entities Focused on Synthetic Biology Research Globally: 2009 & 2013 (includes corresponding Graph/Chart)
    • Table 2: Synthetic Biology and their Potential Areas of Applications Being Researched by Biological Systems Manufacturers/Designers (includes corresponding Graph/Chart)
    • Table 3: Number of Biological Systems Manufacturers/Designers Focused on Specialty/Fine Chemical Applications (includes corresponding Graph/Chart)
    • Table 4: Number of Patent Filings Related to Synthetic Biology: 2003-2013 (includes corresponding Graph/Chart)
    • Table 5: Leading Filers of Patent Applications Related to Synthetic Biology: 2003-2013 (includes corresponding Graph/Chart)
  • Synthetic Biology Mired by Challenges in Developing Countries
  • Synthetic Biology Bringing a Paradigm Shift in the Field of Biological Research
  • DNA Sequencing Technique Propelling Growth for Synthetic Biology
  • Plummeting Cost of DNA Sequencing Bolsters Market Growth
    • Table 6: Cost per Genome Sequencing: 2001-2014
  • Systems Biology Leading to Advancements in Synthetic Biology
  • Synthetic Biology based Microbial Factories for Production of Poppies
  • Food and Other Basic Needs' Scarcity to Fuel Synthetic Biology Market
  • Food, Water, and Energy Statistics
    • Table 7: Top 20 Countries Worldwide in Terms of Population in Million (2014) (includes corresponding Graph/Chart)
  • Will Synthetic Biology Mitigate Food Security Concerns?
  • Growing Demand for GM Crops Opens Up Growth Avenues
  • Synthetic Biology-based Ingredients Gain Traction
  • Role of Synthetic Biology in Producing Plants with Desirable Characteristics
  • Do-It-Yourself Biology (DIYBio): A Growing Phenomenon
  • Synthetic Biology Ingredients in Consumer Products - Laden with Concerns
  • Synthetic Biology Gaining Prominence in Biomedical Applications
  • Research Efforts in Full Swing to Treat Life-Threatening Diseases using Synthetic Biology
  • Synthetic Biology Therapeutics to Address Antibiotic-Resistance Crisis
  • Pipeline Perspective of Synthetic Biology Therapeutics (Synthetic Biologics and Intrexon Collaboration)
  • Synthetic Biology for Wildlife Conservation Laden with Risks
  • Synthetic Biology Enabling Creation of Advanced Biosensing Systems
  • Synthetic Biology Gains Significance in Production of Bio-Based Chemicals and Biofuels
  • Contribution of Synthetic Biology to Renewable Chemicals
  • Synthetic Biology for Energy Supply: Potential Threat to Biodiversity
  • SynBio Products and Ingredients Face Opposition from Several Organizations
  • Lack of Regulatory Framework - A Major Concern

4. KEY RESEARCH FINDINGS ON SYNTHETIC BIOLOGY

  • Biologists Implants Artificial Chromosome in Yeast to Create Artificial Life
  • Synthetic Genes to Open New World of Drug Development
  • Researchers Announce Production of Peptoid Nanosheets
  • Synthetic Biology in Repelling Viruses
  • Synthetic Biology in Engineered Food
  • Synthetic Biology to Address Issues Related to Algal Blooms
  • Synthetic Biology Holds Potential for Testing Water Purity
  • Mars - A Home Away from Home Courtesy Synthetic Biology
  • Predictable Biological Systems - No More a Myth
  • Researchers at JCVI Make Novel Advances in Synthetic Genomics
  • Synthetic Biology Tools Can Detect Listeria Contamination in Food Products
  • Synthetic Biology Accelerates Flu Vaccine Production
  • Bioengineers at Duke University Develops Novel System for Reproducing Natural Complex Gene Regulation
  • TALE: A Viable Technology for Synthetic Protein Development
  • Can Synthetic Biology Fuel Cars or Household Power Supplies Using Naturally-Existing Fatty Acids?
  • Researchers Engineered Synthetic Compound to Defend Iron Deficiency
  • Cellular Circuit Designing Made Possible through Biological Genes
  • Meshing Inputs/Outputs Offer Layered Circuits
  • Cambrian Genomics Pioneers DNA Laser Printer
  • Researchers Develop Novel Technique that Speeds the Process for Developing New Biological Parts
  • Researchers Develop Novel Biological Device that Mimics Transistor-Like Properties

5. SYNTHETIC BIOLOGY - AN OVERVIEW

  • Introduction
  • Historical Background
  • Synthetic Biology Vis-a-vis Genetic Engineering - A Comparison
  • Scope of Synthetic Biology in Various Fields
  • Engineering
  • Chemistry
  • Major Enabling Technologies
  • Sequencing
  • Fabrication
  • Modeling
  • Measurement
  • Synthetic Biology Market - By Product
  • Core Products/Biologic Components
    • Synthetic Genes
    • Synthetic Cells
    • Chassis Organisms
      • Escherichia coli
      • Bacillus subtilis
      • Yeast
      • Mycoplasma
      • Acinetobacter
      • Mycoplasma genitalium
    • XNA (Xeno Nucleic Acid)
  • Enabling Products
    • DNA Synthesis
    • Oligonucleotide Synthesis
  • Market Potential
  • Pharmaceutical
  • Industrial
  • Agriculture
  • Life Sciences Research
  • Renewable Energy
    • Synthetic Biology Applications/Products with Highest Potential for Commercialization by 2030
  • Potential Uses
  • Biomedicine
    • Intricate Molecular Devices Utilized for Tissue Regeneration/Repair
    • Smart Drugs
    • Biological Delivery Systems
    • Vectors for Therapy
    • Personalized Medicine
    • Cells with Novel Properties for Betterment of Human Health
  • In Vivo Synthesis of Small-Molecule Pharmaceuticals
    • Intricate Natural Products
  • Expansion of Chemistry of Life
    • Expanding Genetic Alphabet
    • Nucleic Acids
    • Proteins
    • New Imaging and Targeting Methods
  • Chemical Industry Sustainability
    • Eco-friendly Production of Chemicals
  • Energy and Environment
    • Bioremediation
    • Energy Production
  • Biomaterials and Smart Materials Production
    • Synthesis
    • Organization
  • Socio-Economic Concerns and Risks of Synthetic Biology
  • Production of Bio-Weapons
  • Accidental Release
  • Return on Investment
  • Dissonance with Other Disciplines
  • Continuous Evolution
  • Curtailed Understanding
  • Unpredictable Ecosystem Effects
  • Unexpected Transfer of Genes
  • Aggravating Problems
  • Industry Associations
  • Synthetic Biology Industry Association (SynBIA)
  • Industry Association of Synthetic Biology (IASB)

6. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Synthetic Biologics Obtains Orphan Drug Designation for SYN-005 mAb
  • Agilent Technologies Introduces SureGuide Kits
  • Agilent Technologies Rolls Out ClearSeq AML Next-Generation Sequencing Cancer Research Panels
  • Gen9 Rolls Out Variant Libraries
  • Gen9 Introduces GeneByte Plus™ DNA Constructs
  • Agilent Technologies Introduces SureSelect Clinical Research Exome
  • Agilent Technologies Launches QuikChange HT Protein Engineering Synthetic Biology System
  • GenScript Introduces GenEZ™ Next-Generation Molecular Cloning Service
  • DNA2.0 Releases CRISPR/Cas9 Tools for Genome Editing and Engineering
  • GenScript Unveils GenPlus™ Next-Generation Gene Synthesis Technology
  • Life Technologies Introduces new GeneArt® Algae Protein Expression Kits
  • Life Technologies Unveils Vector NTI® Express Designer Bioinformatics Software Platform
  • Gen9 Introduces GeneBytes™ DNA Constructs
  • New England Biolabs and Synthetic Genomics Launches Gibson Assembly Cloning Kit and NEBuilder™ Primer Design Tool
  • GenScript Introduces Gene-Brick™ Gene Synthesis Service

7. RECENT INDUSTRY ACTIVITY

  • Genome Compiler Enters into Collaborative Agreement with DNA2.0
  • Eurofins Genomics Enters into Co-operation Agreement with Igenbio
  • Bacterial Robotics Signs Strategic Agreement with Bacmine
  • Intrexon and Histogenics Enter into Exclusive Channel Collaboration for Cartilage Repair Therapies
  • Intrexon and Amneal Pharmaceuticals Announce Second Exclusive Channel Collaboration for a Target API
  • Synthetic Biologics and FUJIFILM Diosynth Biotechnologies Announces Positive Phase I Outcomes of API Manufacturing of SYN-004
  • Evolva Holding Acquires Prosarix
  • Igenbio Collaborates with Genome Compiler
  • Pareto Biotechnologies Enters into Technology Partnership with DNA2.0
  • Roche Enters into Research Agreement with Stratos Genomics
  • Cellectis Enters into Agreement with Thermo Fisher Scientific
  • Roche Acquires Genia Technologies
  • Synthorx, a New Synthetic Biotechnology Company Launches
  • Synthetic Genomics Enters into Long-Term R&D Agreement with Lung Biotechnology
  • OriGene Introduces Genome-wide Gene-knockout Kits
  • Intrexon Concludes Acquisition of Medistem
  • Amyris Enters into Collaborative R&D Agreement with BASF
  • MIT SBC Collaborates with Pfizer
  • Tauriga Sciences Acquires Pilus Energy LLC
  • OvaScience and Intrexon Enter into Agreement
  • Sanofi Commences Large-Scale Production of Semi-Synthetic Artemisinin
  • EVOLVA and IFF Enter into Pre-Manufacturing Phase for Natural Vanillin
  • Synthetic Genomics Enters into Research Agreement with ExxonMobil
  • Amyris Signs Long Term Agreement with International Flavors & Fragrances
  • SGI-DNA and IDT Announce Expanded Collaboration
  • College of Engineering Establishes BU Center of Synthetic Biology
  • Gen9 Enters into Partnership with Agilent Technologies
  • AquaBounty Technologies Enters into Exclusive Channel Collaboration with Intrexon
  • Synthetic Biologics Collaborates with Intrexon for Infectious Disease Therapies
  • DuPont Collaborates with OligoCo
  • DNA2.0 Collaborates with Newcastle University
  • Amyris Secures Contract from the US DARPA
  • Pfenex Collaborates with DNA2.0
  • Synthetic Genomics Inks Agreement with New England Biolabs
  • Amyris Commences Production of Biofene in Brazil

8. FOCUS ON SELECT PLAYERS

  • Players Focused on Synthetic Biology Applications
  • Amyris, Inc. (US)
  • BP PLC. (UK)
  • Chromatin Inc. (US)
  • Evolva SA (Switzerland)
  • Gevo, Inc. (US)
  • Joule Unlimited, Inc. (US)
  • Metabolix (US)
  • MorphoSys AG (Germany)
  • Sapphire Energy, Inc. (US)
  • Solazyme, Inc. (US)
  • Synthetic Biologics, Inc. (US)
  • Synthetic Genomics, Inc. (US)
  • Players Focused on Gene Synthesis and Tools
  • 454 Life Sciences (US)
  • Agilent Technologies Inc. (US)
  • ATG Biosynthetics GmbH (Germany)
  • DNA2.0 (US)
  • Epoch Life Science, Inc. (US)
  • Gen9, Inc. (US)
  • GenScript USA, Inc. (US)
  • Gingko Bioworks, Inc. (US)
  • Intrexon Corporation (US)
  • LC Sciences LLC (US)
  • Life Technologies Corp. (US)
  • OPXBIO, Inc. (US)
  • OriGene Technologies, Inc. (US)
  • Sangamo BioSciences, Inc. (US)
  • Verdezyne, Inc. (US)

9. GLOBAL MARKET PERSPECTIVE

    • Table 8: World Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 9: World Historic Review for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 10: World 14-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 11: World Recent Past, Current & Future Analysis for Synthetic Biology by Product Segment - Enabled Products and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 12: World Historic Review for Synthetic Biology by Product Segment - Enabled Products and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 13: World 14-Year Perspective for Synthetic Biology by Product Segment - Percentage Breakdown of Dollar Sales for Enabled Products and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 14: World Recent Past, Current & Future Analysis for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 15: World Historic Review for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 16: World 14-Year Perspective for Synthetic Biology by End-Use Sector - Percentage Breakdown of Dollar Sales for Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Research in the US
    • Table 17: Number of Entities Focused on Synthetic Biology Research in the US (2009 & 2013) (includes corresponding Graph/Chart)
    • International Genetically Engineered Machine (IGEM) - A Platform for Innovations
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 18: US Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: US Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 20: Canadian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 21: Canadian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN

  • Market Analysis
    • Table 22: Japanese Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 23: Japanese Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Research in Europe
    • Table 24: Number of Entities Focused on Synthetic Biology Research in Europe (2009 & 2013) (includes corresponding Graph/Chart)
    • Table 25: Number of Entities Focused on Synthetic Biology Research by Area of Interest: 2013 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 26: European Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 27: European Historic Review for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 28: European 14-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 29: French Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 30: French Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Key Players
  • B. Market Analytics
    • Table 31: German Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 32: German Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 33: Italian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 34: Italian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Market Overview
    • UK Government Awards Over £6 Million Grant for Synthetic Biology
      • UK Government Funding for Synthetic Biology: 2013
    • Synbicite Centre to Spearhead UK Research In Synthetic Biology
    • UK Sets Up New Synthetic Biology Research Centers
      • Synthetic Biology Research Centre Nottingham (Sbrc Nottingham)
      • Bristol Centre for Synthetic Biology (Brissynbio)
      • Openplant Synthetic Biology Research Centre
    • University of Edinburgh inks Agreement with Bgi to Develop Artificial Yeast Genome
    • Strategic Corporate Development
    • BP Plc. - A Key Player
  • B. Market Analytics
    • Table 35: UK Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 36: UK Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 37: Spanish Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 38: Spanish Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4f. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Evolva SA (Switzerland) - A Major Player
  • B. Market Analytics
    • Table 39: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 40: Rest of Europe Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Table 41: Number of Entities Focused on Synthetic Biology Research in Asia and Oceania in 2013 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 42: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 43: Asia-Pacific Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 44: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 45: Rest of World Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top